Editorial Board
Dr. Kumar Pranav Narayan
Assistant Professor, Department of Biological Sciences, Birla Institute of Technology & Science · India
Editorial leadership for Journal of Cancer Genetics And Biomarkers ISSN 2572-3030
Research interests
- Cancer Biology
- Diagnostics
- Therapeutics
Biography
- Dr. Kumar Pranav Narayan is Assistant Professor in Biological Sciences since 2008.
- He has interest in cancer therapeutics using targeted gene delivery system and phyto-compound.
- He has more than seven years research experience in the Dept. of Microbiology, Indian Agriculture Research Institute, New Delhi.
- He has worked on inter-strain competition of Mesorhizobium ciceri on the basis of bacteriocin production; raised antibody against these strains and used several immunological technique to identify these strains from the soil.
- He has also worked on molecular biodiversity of cyanobacteria using AFLP as technique.
Selected publications
- Glucocorticoid Receptor-Targeted Nanoliposome for STAT3 Inhibition-Led Myeloid-Derived Suppressor Cell Modulation and Efficient Colon Cancer Treatment Recent 2025 cited 5×
- Regulatory crosstalk between TGF-β signaling and miRNAs: a head and neck cancer perspective 2024 cited 3×
- Steroid hormone receptor based gene delivery systems as potential oral cancer therapeutics 2024 cited 3×
- Glucocorticoid receptor-mediated delivery of paclitaxel and anticancer gene p53 for oral cancer therapeutics Recent 2025 cited 3×
- N6-methyladenosine RNA modification in head and neck squamous cell carcinoma (HNSCC): current status and future insights 2024 cited 1×
- Transforming growth factor-beta (TGF-β) mediated induction of miR-21-5p drives oral squamous cell carcinoma (OSCC) progression through suppression of KLF5 Recent 2026
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JCGB for your work?
This journal is guided by Dr. Kumar Pranav Narayan (Assistant Professor, Department of Biological Sciences, Birla Institute of Technology & Science) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.